{"entity":{"type":"insider","cik":"0001603510","url":"/insider/0001603510","json_url":"/insider/0001603510.json","name":"Primiano Christopher Brett","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":22,"first":"2014-05-13","last":"2020-12-03","span_basis":"filed_date"},"name_variants":[{"name":"Primiano Christopher Brett","source":"filing","n_filings":22,"first_seen":"2014-05-13","last_seen":"2020-12-03"}],"transactions":[{"id":2739925,"accession":"0001209191-20-061537","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-061537","line_url":"/filing/0001209191-20-061537","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":137061.0,"shares_display":"137,061","price_per_share":17.526698258439673,"price_display":"17.53","price_state":"stated","total_value":2402226.79,"total_display":"2,402,226.79","total_whole":"2,402,227","shares_owned_after":4523.0,"shares_owned_after_display":"4,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-03","scope":"insider","n_lines":2},{"id":2444855,"accession":"0001209191-20-056883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-056883","line_url":"/filing/0001209191-20-056883#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":772.0,"shares_display":"772","price_per_share":14.92,"price_display":"14.92","price_state":"stated","total_value":11518.24,"total_display":"11,518.24","total_whole":"11,518","shares_owned_after":4523.0,"shares_owned_after_display":"4,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-04","scope":"insider"},{"id":3091555,"accession":"0001209191-20-054825","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-054825","line_url":"/filing/0001209191-20-054825","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39271.0,"shares_display":"39,271","price_per_share":16.856425861322606,"price_display":"16.86","price_state":"stated","total_value":661968.7,"total_display":"661,968.70","total_whole":"661,969","shares_owned_after":4649.0,"shares_owned_after_display":"4,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-13","filed_date":"2020-10-14","scope":"insider","n_lines":2},{"id":2083465,"accession":"0001209191-20-049920","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-049920","line_url":"/filing/0001209191-20-049920#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10054.0,"shares_display":"10,054","price_per_share":14.98,"price_display":"14.98","price_state":"stated","total_value":150608.92,"total_display":"150,608.92","total_whole":"150,609","shares_owned_after":4649.0,"shares_owned_after_display":"4,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2218840,"accession":"0001209191-20-028268","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-028268","line_url":"/filing/0001209191-20-028268","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9660.0,"shares_display":"9,660","price_per_share":19.73366409937888,"price_display":"19.73","price_state":"stated","total_value":190627.1952,"total_display":"190,627.20","total_whole":"190,627","shares_owned_after":4649.0,"shares_owned_after_display":"4,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-11","scope":"insider","n_lines":2},{"id":3255470,"accession":"0001209191-20-016416","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-016416","line_url":"/filing/0001209191-20-016416","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26500.0,"shares_display":"26,500","price_per_share":25.369011320754716,"price_display":"25.37","price_state":"stated","total_value":672278.8,"total_display":"672,278.80","total_whole":"672,279","shares_owned_after":19367.0,"shares_owned_after_display":"19,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider","n_lines":3},{"id":2487730,"accession":"0001209191-20-011692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-011692","line_url":"/filing/0001209191-20-011692#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2961.0,"shares_display":"2,961","price_per_share":16.4819,"price_display":"16.48","price_state":"stated","total_value":48802.9059,"total_display":"48,802.91","total_whole":"48,803","shares_owned_after":10367.0,"shares_owned_after_display":"10,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-21","scope":"insider"},{"id":8601900,"accession":"0001209191-19-062196","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-062196","line_url":"/filing/0001209191-19-062196#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":3653.0,"shares_owned_after_display":"3,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-27","filed_date":"2019-12-31","scope":"insider"},{"id":7885727,"accession":"0001209191-19-059914","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-059914","line_url":"/filing/0001209191-19-059914","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":17.454461538461537,"price_display":"17.45","price_state":"stated","total_value":226908.0,"total_display":"226,908.00","total_whole":"226,908","shares_owned_after":11653.0,"shares_owned_after_display":"11,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-06","filed_date":"2019-12-10","scope":"insider","n_lines":3},{"id":6559834,"accession":"0001209191-18-050553","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-050553","line_url":"/filing/0001209191-18-050553#line-3","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.9046,"price_display":"18.90","price_state":"stated","total_value":189046.0,"total_display":"189,046.00","total_whole":"189,046","shares_owned_after":2881.0,"shares_owned_after_display":"2,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-10","filed_date":"2018-09-11","scope":"insider"},{"id":6861898,"accession":"0001209191-18-029243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-029243","line_url":"/filing/0001209191-18-029243#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":18.012,"price_display":"18.01","price_state":"stated","total_value":36024.0,"total_display":"36,024.00","total_whole":"36,024","shares_owned_after":2881.0,"shares_owned_after_display":"2,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-10","filed_date":"2018-05-10","scope":"insider"},{"id":6099500,"accession":"0001209191-18-017330","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-017330","line_url":"/filing/0001209191-18-017330#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":16.0304,"price_display":"16.03","price_state":"stated","total_value":40076.0,"total_display":"40,076.00","total_whole":"40,076","shares_owned_after":4881.0,"shares_owned_after_display":"4,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-06","scope":"insider"},{"id":6356500,"accession":"0001209191-18-011324","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-011324","line_url":"/filing/0001209191-18-011324#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1486.0,"shares_display":"1,486","price_per_share":15.0054,"price_display":"15.01","price_state":"stated","total_value":22298.0244,"total_display":"22,298.02","total_whole":"22,298","shares_owned_after":7381.0,"shares_owned_after_display":"7,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-16","filed_date":"2018-02-20","scope":"insider"},{"id":6356493,"accession":"0001209191-18-011324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-011324","line_url":"/filing/0001209191-18-011324#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1014.0,"shares_display":"1,014","price_per_share":15.0187,"price_display":"15.02","price_state":"stated","total_value":15228.9618,"total_display":"15,228.96","total_whole":"15,229","shares_owned_after":8867.0,"shares_owned_after_display":"8,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-20","scope":"insider"},{"id":6257425,"accession":"0001209191-18-008420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-008420","line_url":"/filing/0001209191-18-008420#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (EVP, CBO, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CBO, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CBO, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":19500.0,"total_display":"19,500.00","total_whole":"19,500","shares_owned_after":9881.0,"shares_owned_after_display":"9,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-07","filed_date":"2018-02-08","scope":"insider"},{"id":4424289,"accession":"0001209191-17-065406","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-065406","line_url":"/filing/0001209191-17-065406","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark":"O","role_mark_label":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, OPS, BUS DEV, GC & SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":9.918577552941176,"price_display":"9.92","price_state":"stated","total_value":168615.8184,"total_display":"168,615.82","total_whole":"168,616","shares_owned_after":12025.0,"shares_owned_after_display":"12,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2017-12-13","scope":"insider","n_lines":2},{"id":4424272,"accession":"0001209191-17-065406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-065406","line_url":"/filing/0001209191-17-065406#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark":"O","role_mark_label":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, OPS, BUS DEV, GC & SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10042.0,"shares_display":"10,042","price_per_share":10.8799,"price_display":"10.88","price_state":"stated","total_value":109255.9558,"total_display":"109,255.96","total_whole":"109,256","shares_owned_after":11381.0,"shares_owned_after_display":"11,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-11","filed_date":"2017-12-13","scope":"insider"},{"id":4112020,"accession":"0001209191-17-059944","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-059944","line_url":"/filing/0001209191-17-059944#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark":"O","role_mark_label":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, OPS, BUS DEV, GC & SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4958.0,"shares_display":"4,958","price_per_share":11.2455,"price_display":"11.25","price_state":"stated","total_value":55755.189,"total_display":"55,755.19","total_whole":"55,755","shares_owned_after":21423.0,"shares_owned_after_display":"21,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-07","filed_date":"2017-11-09","scope":"insider"},{"id":4111598,"accession":"0001209191-17-055750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-055750","line_url":"/filing/0001209191-17-055750#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark":"O","role_mark_label":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, OPS, BUS DEV, GC & SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":11381.0,"shares_owned_after_display":"11,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":4832969,"accession":"0001209191-17-053148","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-053148","line_url":"/filing/0001209191-17-053148#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark":"O","role_mark_label":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, OPS, BUS DEV, GC & SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":22000.0,"total_display":"22,000.00","total_whole":"22,000","shares_owned_after":12881.0,"shares_owned_after_display":"12,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-15","filed_date":"2017-09-18","scope":"insider"},{"id":4111004,"accession":"0001209191-17-050698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-050698","line_url":"/filing/0001209191-17-050698#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark":"O","role_mark_label":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, OPS, BUS DEV, GC & SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2195.0,"shares_display":"2,195","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":21950.0,"total_display":"21,950.00","total_whole":"21,950","shares_owned_after":15686.0,"shares_owned_after_display":"15,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-29","filed_date":"2017-08-30","scope":"insider"},{"id":4945142,"accession":"0001209191-17-051076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-051076","line_url":"/filing/0001209191-17-051076#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark":"O","role_mark_label":"Officer (SVP, OPS, BUS DEV, GC & SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, OPS, BUS DEV, GC & SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":805.0,"shares_display":"805","price_per_share":10.0261,"price_display":"10.03","price_state":"stated","total_value":8071.0105,"total_display":"8,071.01","total_whole":"8,071","shares_owned_after":14881.0,"shares_owned_after_display":"14,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-09-01","scope":"insider"},{"id":2927859,"accession":"0001209191-16-149846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-149846","line_url":"/filing/0001209191-16-149846#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (SVP,CORP DEV,GEN COUNSEL&SEC)","role_mark":"O","role_mark_label":"Officer (SVP,CORP DEV,GEN COUNSEL&SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP,CORP DEV,GEN COUNSEL&SEC.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4342.0,"shares_display":"4,342","price_per_share":8.1862,"price_display":"8.19","price_state":"stated","total_value":35544.4804,"total_display":"35,544.48","total_whole":"35,544","shares_owned_after":15819.0,"shares_owned_after_display":"15,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-14","scope":"insider"},{"id":6959477,"accession":"0001179110-14-008321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-008321","line_url":"/filing/0001179110-14-008321#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001603510","owner_name":"Primiano Christopher Brett","owner_display_name":"Primiano Christopher Brett","owner_url":"/insider/0001603510","role":"Officer (VP, GEN COUNSEL & SECRETARY)","role_mark":"O","role_mark_label":"Officer (VP, GEN COUNSEL & SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, GEN COUNSEL & SECRETARY","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":26.75,"price_display":"26.75","price_state":"stated","total_value":26750.0,"total_display":"26,750.00","total_whole":"26,750","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-13","filed_date":"2014-05-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (EVP, CBO, GC & Secretary)","n_filings":22,"first_seen":"2014-05-13","last_seen":"2020-12-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001603510","retrieved_at":"2026-08-27T01:14:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}